nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—Fulvestrant—breast cancer	0.31	1	CrCtD
Estradiol—GPER1—breast cancer	0.0789	0.371	CbGaD
Estradiol—ESRRA—breast cancer	0.0508	0.239	CbGaD
Estradiol—Conjugated Estrogens—Exemestane—breast cancer	0.0382	0.296	CrCrCtD
Estradiol—Estropipate—Exemestane—breast cancer	0.0382	0.296	CrCrCtD
Estradiol—ESRRA—Fulvestrant—breast cancer	0.0375	0.169	CbGbCtD
Estradiol—Estrone—Exemestane—breast cancer	0.0283	0.219	CrCrCtD
Estradiol—SLCO1B1—breast cancer	0.0157	0.0736	CbGaD
Estradiol—ESRRA—Tamoxifen—breast cancer	0.0148	0.0664	CbGbCtD
Estradiol—Testosterone—Exemestane—breast cancer	0.0145	0.112	CrCrCtD
Estradiol—ESR2—Fulvestrant—breast cancer	0.0116	0.0523	CbGbCtD
Estradiol—ESR2—breast cancer	0.0108	0.0509	CbGaD
Estradiol—Testosterone—Fluoxymesterone—breast cancer	0.01	0.0777	CrCrCtD
Estradiol—CYP1B1—breast cancer	0.00988	0.0465	CbGaD
Estradiol—SHBG—breast cancer	0.00988	0.0465	CbGaD
Estradiol—SHBG—Fluoxymesterone—breast cancer	0.00885	0.0398	CbGbCtD
Estradiol—AR—breast cancer	0.00867	0.0407	CbGaD
Estradiol—AR—Fluoxymesterone—breast cancer	0.00741	0.0333	CbGbCtD
Estradiol—ESR2—Raloxifene—breast cancer	0.00691	0.0311	CbGbCtD
Estradiol—ABCG2—breast cancer	0.00682	0.032	CbGaD
Estradiol—ESR1—breast cancer	0.00668	0.0314	CbGaD
Estradiol—ESR1—Toremifene—breast cancer	0.0064	0.0288	CbGbCtD
Estradiol—ESR1—Fluoxymesterone—breast cancer	0.0064	0.0288	CbGbCtD
Estradiol—AOX1—Raloxifene—breast cancer	0.00616	0.0277	CbGbCtD
Estradiol—ESR1—Fulvestrant—breast cancer	0.00595	0.0268	CbGbCtD
Estradiol—SLC22A3—Melphalan—breast cancer	0.00577	0.026	CbGbCtD
Estradiol—CYP1A1—breast cancer	0.00534	0.0251	CbGaD
Estradiol—NR1I2—Paclitaxel—breast cancer	0.00477	0.0215	CbGbCtD
Estradiol—ESR2—Tamoxifen—breast cancer	0.00456	0.0205	CbGbCtD
Estradiol—ABCC10—Gemcitabine—breast cancer	0.00371	0.0167	CbGbCtD
Estradiol—ESR1—Raloxifene—breast cancer	0.00354	0.0159	CbGbCtD
Estradiol—NR1I2—Docetaxel—breast cancer	0.00345	0.0155	CbGbCtD
Estradiol—CYP3A4—breast cancer	0.00341	0.016	CbGaD
Estradiol—SLCO1A2—Chlorambucil—breast cancer	0.00336	0.0151	CbGbCtD
Estradiol—ABCC10—Paclitaxel—breast cancer	0.00335	0.0151	CbGbCtD
Estradiol—ALB—breast cancer	0.00297	0.014	CbGaD
Estradiol—ABCB1—breast cancer	0.00284	0.0133	CbGaD
Estradiol—CYP1A1—Toremifene—breast cancer	0.00281	0.0126	CbGbCtD
Estradiol—ABCC10—Docetaxel—breast cancer	0.00242	0.0109	CbGbCtD
Estradiol—ESR1—Tamoxifen—breast cancer	0.00234	0.0105	CbGbCtD
Estradiol—CYP1B1—Tamoxifen—breast cancer	0.00234	0.0105	CbGbCtD
Estradiol—CYP1B1—Mitoxantrone—breast cancer	0.00228	0.0103	CbGbCtD
Estradiol—SLC22A3—Irinotecan—breast cancer	0.00195	0.00879	CbGbCtD
Estradiol—SLCO1B3—Paclitaxel—breast cancer	0.00187	0.00841	CbGbCtD
Estradiol—CYP1B1—Paclitaxel—breast cancer	0.00182	0.00819	CbGbCtD
Estradiol—ABCC10—Doxorubicin—breast cancer	0.0018	0.00812	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—breast cancer	0.00175	0.00787	CbGbCtD
Estradiol—ABCC10—Methotrexate—breast cancer	0.00175	0.00787	CbGbCtD
Estradiol—AOX1—Methotrexate—breast cancer	0.00165	0.00744	CbGbCtD
Estradiol—UGT1A1—Irinotecan—breast cancer	0.00155	0.00698	CbGbCtD
Estradiol—CYP1A2—Anastrozole—breast cancer	0.00137	0.00617	CbGbCtD
Estradiol—SLCO1B3—Docetaxel—breast cancer	0.00135	0.00608	CbGbCtD
Estradiol—CYP1B1—Docetaxel—breast cancer	0.00132	0.00592	CbGbCtD
Estradiol—CYP1A2—Toremifene—breast cancer	0.00125	0.00565	CbGbCtD
Estradiol—CYP2C9—Anastrozole—breast cancer	0.00124	0.00556	CbGbCtD
Estradiol—CYP3A5—Lapatinib—breast cancer	0.00123	0.00553	CbGbCtD
Estradiol—CYP2C8—Lapatinib—breast cancer	0.00118	0.00532	CbGbCtD
Estradiol—ABCG2—Tamoxifen—breast cancer	0.00111	0.005	CbGbCtD
Estradiol—ABCB1—Toremifene—breast cancer	0.0011	0.00494	CbGbCtD
Estradiol—ABCG2—Mitoxantrone—breast cancer	0.00108	0.00488	CbGbCtD
Estradiol—SLCO1B1—Irinotecan—breast cancer	0.00107	0.00483	CbGbCtD
Estradiol—SLC22A2—Vinblastine—breast cancer	0.00103	0.00463	CbGbCtD
Estradiol—CYP1A1—Tamoxifen—breast cancer	0.00103	0.00462	CbGbCtD
Estradiol—CYP2C19—Lapatinib—breast cancer	0.000992	0.00446	CbGbCtD
Estradiol—CYP1B1—Doxorubicin—breast cancer	0.000981	0.00441	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—breast cancer	0.000976	0.00439	CbGbCtD
Estradiol—CYP3A4—Exemestane—breast cancer	0.000948	0.00427	CbGbCtD
Estradiol—CYP2C9—Idarubicin—breast cancer	0.000937	0.00421	CbGbCtD
Estradiol—SLC22A11—Methotrexate—breast cancer	0.000902	0.00406	CbGbCtD
Estradiol—CYP2C8—Raloxifene—breast cancer	0.000896	0.00403	CbGbCtD
Estradiol—ABCG2—Paclitaxel—breast cancer	0.000865	0.00389	CbGbCtD
Estradiol—ABCG2—Irinotecan—breast cancer	0.000853	0.00384	CbGbCtD
Estradiol—CYP3A7—Tamoxifen—breast cancer	0.000821	0.00369	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.000821	0.00369	CbGbCtD
Estradiol—ABCG2—Fluorouracil—breast cancer	0.000819	0.00369	CbGbCtD
Estradiol—ABCG2—Carboplatin—breast cancer	0.000814	0.00366	CbGbCtD
Estradiol—CYP3A4—Letrozole—breast cancer	0.000806	0.00363	CbGbCtD
Estradiol—ABCB1—Lapatinib—breast cancer	0.0008	0.0036	CbGbCtD
Estradiol—CYP3A4—Anastrozole—breast cancer	0.000719	0.00323	CbGbCtD
Estradiol—CYP3A4—Toremifene—breast cancer	0.000657	0.00296	CbGbCtD
Estradiol—CYP3A7—Paclitaxel—breast cancer	0.000639	0.00287	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.000639	0.00287	CbGbCtD
Estradiol—CYP3A7—Irinotecan—breast cancer	0.00063	0.00284	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00063	0.00284	CbGbCtD
Estradiol—ABCG2—Docetaxel—breast cancer	0.000625	0.00281	CbGbCtD
Estradiol—CYP3A5—Tamoxifen—breast cancer	0.000616	0.00277	CbGbCtD
Estradiol—CYP3A4—Fulvestrant—breast cancer	0.000611	0.00275	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—breast cancer	0.000603	0.00271	CbGbCtD
Estradiol—CYP2C8—Tamoxifen—breast cancer	0.000592	0.00266	CbGbCtD
Estradiol—ALB—Irinotecan—breast cancer	0.000588	0.00265	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—breast cancer	0.000569	0.00256	CbGbCtD
Estradiol—FABP2—embryo—breast cancer	0.000566	0.03	CbGeAlD
Estradiol—ALB—Fluorouracil—breast cancer	0.000565	0.00254	CbGbCtD
Estradiol—CYP3A4—Thiotepa—breast cancer	0.000545	0.00245	CbGbCtD
Estradiol—SLC22A8—Methotrexate—breast cancer	0.000525	0.00236	CbGbCtD
Estradiol—CYP2C9—Capecitabine—breast cancer	0.000513	0.00231	CbGbCtD
Estradiol—CYP3A4—Ixabepilone—breast cancer	0.000498	0.00224	CbGbCtD
Estradiol—CYP2C19—Tamoxifen—breast cancer	0.000497	0.00223	CbGbCtD
Estradiol—CYP3A4—Lapatinib—breast cancer	0.00048	0.00216	CbGbCtD
Estradiol—CYP3A5—Paclitaxel—breast cancer	0.000479	0.00216	CbGbCtD
Estradiol—CYP3A5—Irinotecan—breast cancer	0.000473	0.00213	CbGbCtD
Estradiol—ABCG2—Doxorubicin—breast cancer	0.000466	0.0021	CbGbCtD
Estradiol—FABP2—epithelium—breast cancer	0.000462	0.0244	CbGeAlD
Estradiol—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.000462	0.00208	CbGbCtD
Estradiol—CYP3A7—Docetaxel—breast cancer	0.000462	0.00208	CbGbCtD
Estradiol—CYP2C8—Paclitaxel—breast cancer	0.000461	0.00207	CbGbCtD
Estradiol—Fulvestrant—ESRRA—breast cancer	0.000459	0.263	CrCbGaD
Estradiol—CYP1A2—Tamoxifen—breast cancer	0.000458	0.00206	CbGbCtD
Estradiol—ESRRB—female reproductive system—breast cancer	0.000453	0.024	CbGeAlD
Estradiol—ABCG2—Methotrexate—breast cancer	0.000452	0.00203	CbGbCtD
Estradiol—ABCB1—Vinorelbine—breast cancer	0.000444	0.002	CbGbCtD
Estradiol—CYP2C8—Fluorouracil—breast cancer	0.000436	0.00196	CbGbCtD
Estradiol—CYP2C9—Tamoxifen—breast cancer	0.000413	0.00186	CbGbCtD
Estradiol—ABCB1—Tamoxifen—breast cancer	0.000401	0.0018	CbGbCtD
Estradiol—ABCB1—Mitoxantrone—breast cancer	0.000391	0.00176	CbGbCtD
Estradiol—ESRRB—endocrine gland—breast cancer	0.000383	0.0203	CbGeAlD
Estradiol—GPER1—endometrium—breast cancer	0.000376	0.0199	CbGeAlD
Estradiol—CYP3A4—Raloxifene—breast cancer	0.000363	0.00164	CbGbCtD
Estradiol—CYP3A5—Docetaxel—breast cancer	0.000347	0.00156	CbGbCtD
Estradiol—GPER1—uterus—breast cancer	0.000346	0.0183	CbGeAlD
Estradiol—ABCB1—Gemcitabine—breast cancer	0.000345	0.00155	CbGbCtD
Estradiol—GPER1—adipose tissue—breast cancer	0.000339	0.0179	CbGeAlD
Estradiol—CYP1A2—Fluorouracil—breast cancer	0.000338	0.00152	CbGbCtD
Estradiol—CYP2C9—Paclitaxel—breast cancer	0.000321	0.00145	CbGbCtD
Estradiol—ABCB1—Paclitaxel—breast cancer	0.000312	0.0014	CbGbCtD
Estradiol—ALB—Methotrexate—breast cancer	0.000311	0.0014	CbGbCtD
Estradiol—GPER1—female reproductive system—breast cancer	0.000311	0.0165	CbGeAlD
Estradiol—ABCB1—Irinotecan—breast cancer	0.000308	0.00138	CbGbCtD
Estradiol—CYP2C9—Fluorouracil—breast cancer	0.000304	0.00137	CbGbCtD
Estradiol—GPER1—adrenal gland—breast cancer	0.000304	0.0161	CbGeAlD
Estradiol—FABP2—endocrine gland—breast cancer	0.000291	0.0154	CbGeAlD
Estradiol—ESRRA—nipple—breast cancer	0.000289	0.0153	CbGeAlD
Estradiol—ABCB1—Vinblastine—breast cancer	0.000274	0.00123	CbGbCtD
Estradiol—CYP3A4—Vinorelbine—breast cancer	0.000266	0.0012	CbGbCtD
Estradiol—GPER1—endocrine gland—breast cancer	0.000263	0.0139	CbGeAlD
Estradiol—CYP3A4—Tamoxifen—breast cancer	0.00024	0.00108	CbGbCtD
Estradiol—SLCO4A1—mammary gland—breast cancer	0.000237	0.0125	CbGeAlD
Estradiol—CYP3A4—Mitoxantrone—breast cancer	0.000234	0.00105	CbGbCtD
Estradiol—ABCB1—Docetaxel—breast cancer	0.000226	0.00101	CbGbCtD
Estradiol—NR1I2—endocrine gland—breast cancer	0.00022	0.0116	CbGeAlD
Estradiol—ESR2—mammary gland—breast cancer	0.00021	0.0111	CbGeAlD
Estradiol—SLCO1B1—mammary gland—breast cancer	0.000208	0.011	CbGeAlD
Estradiol—FABP2—lymph node—breast cancer	0.000201	0.0106	CbGeAlD
Estradiol—SLCO4A1—nipple—breast cancer	0.000196	0.0104	CbGeAlD
Estradiol—CYP3A4—Paclitaxel—breast cancer	0.000187	0.000841	CbGbCtD
Estradiol—CYP3A4—Irinotecan—breast cancer	0.000184	0.00083	CbGbCtD
Estradiol—SLCO2B1—mammary gland—breast cancer	0.000184	0.00974	CbGeAlD
Estradiol—GPER1—lymph node—breast cancer	0.000182	0.00963	CbGeAlD
Estradiol—ESRRA—endometrium—breast cancer	0.000175	0.00924	CbGeAlD
Estradiol—ALB—mammary gland—breast cancer	0.000169	0.00891	CbGeAlD
Estradiol—ABCB1—Doxorubicin—breast cancer	0.000168	0.000756	CbGbCtD
Estradiol—AOX1—nipple—breast cancer	0.000167	0.00884	CbGeAlD
Estradiol—CYP3A4—Vinblastine—breast cancer	0.000164	0.000738	CbGbCtD
Estradiol—ABCB1—Methotrexate—breast cancer	0.000163	0.000733	CbGbCtD
Estradiol—SLCO1B3—pituitary gland—breast cancer	0.000163	0.00861	CbGeAlD
Estradiol—ABCC10—nipple—breast cancer	0.000163	0.0086	CbGeAlD
Estradiol—ESRRA—uterus—breast cancer	0.000161	0.00851	CbGeAlD
Estradiol—ESRRA—pituitary gland—breast cancer	0.000158	0.00836	CbGeAlD
Estradiol—ESRRA—adipose tissue—breast cancer	0.000157	0.00833	CbGeAlD
Estradiol—CYP1B1—mammary gland—breast cancer	0.000155	0.00818	CbGeAlD
Estradiol—ESRRA—female reproductive system—breast cancer	0.000145	0.00765	CbGeAlD
Estradiol—ESR1—mammary gland—breast cancer	0.000144	0.0076	CbGeAlD
Estradiol—ESRRA—adrenal gland—breast cancer	0.000141	0.00747	CbGeAlD
Estradiol—SLC22A3—nipple—breast cancer	0.000139	0.00736	CbGeAlD
Estradiol—ESRRA—bone marrow—breast cancer	0.000137	0.00723	CbGeAlD
Estradiol—CYP3A4—Docetaxel—breast cancer	0.000135	0.000608	CbGbCtD
Estradiol—SLCO1C1—pituitary gland—breast cancer	0.000134	0.00706	CbGeAlD
Estradiol—SLCO1C1—adipose tissue—breast cancer	0.000133	0.00703	CbGeAlD
Estradiol—ESRRA—female gonad—breast cancer	0.000132	0.00696	CbGeAlD
Estradiol—SLCO1B3—endocrine gland—breast cancer	0.000126	0.00667	CbGeAlD
Estradiol—ESRRA—endocrine gland—breast cancer	0.000122	0.00648	CbGeAlD
Estradiol—AR—nipple—breast cancer	0.000121	0.00641	CbGeAlD
Estradiol—SLC22A11—female reproductive system—breast cancer	0.000119	0.00628	CbGeAlD
Estradiol—CYP2C8—mammary gland—breast cancer	0.000118	0.00626	CbGeAlD
Estradiol—SLCO4A1—endometrium—breast cancer	0.000118	0.00625	CbGeAlD
Estradiol—ESR2—epithelium—breast cancer	0.000117	0.00618	CbGeAlD
Estradiol—SLC22A3—embryo—breast cancer	0.000115	0.00607	CbGeAlD
Estradiol—SLCO4A1—pituitary gland—breast cancer	0.000107	0.00566	CbGeAlD
Estradiol—SLCO4A1—adipose tissue—breast cancer	0.000107	0.00564	CbGeAlD
Estradiol—CYP3A7—endocrine gland—breast cancer	0.000106	0.00562	CbGeAlD
Estradiol—CYP2C9—mammary gland—breast cancer	0.000105	0.00556	CbGeAlD
Estradiol—ESR2—endometrium—breast cancer	0.000105	0.00555	CbGeAlD
Estradiol—SLCO1C1—endocrine gland—breast cancer	0.000103	0.00547	CbGeAlD
Estradiol—SHBG—endometrium—breast cancer	0.000102	0.00539	CbGeAlD
Estradiol—AOX1—endometrium—breast cancer	0.000101	0.00534	CbGeAlD
Estradiol—CYP3A4—Doxorubicin—breast cancer	0.000101	0.000453	CbGbCtD
Estradiol—SLC22A11—endocrine gland—breast cancer	0.0001	0.00531	CbGeAlD
Estradiol—ABCC10—endometrium—breast cancer	9.82e-05	0.0052	CbGeAlD
Estradiol—ESR1—embryo—breast cancer	9.81e-05	0.00519	CbGeAlD
Estradiol—SLCO4A1—female reproductive system—breast cancer	9.79e-05	0.00518	CbGeAlD
Estradiol—Fulvestrant—ESR2—breast cancer	9.78e-05	0.0561	CrCbGaD
Estradiol—ESR2—uterus—breast cancer	9.66e-05	0.00511	CbGeAlD
Estradiol—SLCO4A1—adrenal gland—breast cancer	9.56e-05	0.00506	CbGeAlD
Estradiol—ESR2—pituitary gland—breast cancer	9.49e-05	0.00502	CbGeAlD
Estradiol—SHBG—uterus—breast cancer	9.39e-05	0.00497	CbGeAlD
Estradiol—AOX1—uterus—breast cancer	9.3e-05	0.00492	CbGeAlD
Estradiol—SHBG—pituitary gland—breast cancer	9.22e-05	0.00488	CbGeAlD
Estradiol—SHBG—adipose tissue—breast cancer	9.19e-05	0.00486	CbGeAlD
Estradiol—CYP1A2—nipple—breast cancer	9.17e-05	0.00485	CbGeAlD
Estradiol—AOX1—pituitary gland—breast cancer	9.13e-05	0.00483	CbGeAlD
Estradiol—AOX1—adipose tissue—breast cancer	9.1e-05	0.00481	CbGeAlD
Estradiol—ABCC10—uterus—breast cancer	9.05e-05	0.00479	CbGeAlD
Estradiol—CYP1A1—nipple—breast cancer	9.04e-05	0.00478	CbGeAlD
Estradiol—ABCC10—pituitary gland—breast cancer	8.89e-05	0.0047	CbGeAlD
Estradiol—ABCC10—adipose tissue—breast cancer	8.85e-05	0.00468	CbGeAlD
Estradiol—UGT1A1—endocrine gland—breast cancer	8.76e-05	0.00464	CbGeAlD
Estradiol—ESR2—female reproductive system—breast cancer	8.69e-05	0.00459	CbGeAlD
Estradiol—SLCO1B1—female reproductive system—breast cancer	8.62e-05	0.00456	CbGeAlD
Estradiol—SLCO2B1—uterus—breast cancer	8.48e-05	0.00448	CbGeAlD
Estradiol—ESR2—adrenal gland—breast cancer	8.48e-05	0.00448	CbGeAlD
Estradiol—ESRRA—lymph node—breast cancer	8.47e-05	0.00448	CbGeAlD
Estradiol—SHBG—female reproductive system—breast cancer	8.44e-05	0.00447	CbGeAlD
Estradiol—SLC22A3—endometrium—breast cancer	8.4e-05	0.00444	CbGeAlD
Estradiol—AOX1—female reproductive system—breast cancer	8.36e-05	0.00442	CbGeAlD
Estradiol—SLCO2B1—adipose tissue—breast cancer	8.29e-05	0.00439	CbGeAlD
Estradiol—SLCO4A1—endocrine gland—breast cancer	8.29e-05	0.00438	CbGeAlD
Estradiol—SHBG—adrenal gland—breast cancer	8.24e-05	0.00436	CbGeAlD
Estradiol—CYP1B1—skin of body—breast cancer	8.19e-05	0.00433	CbGeAlD
Estradiol—AOX1—adrenal gland—breast cancer	8.16e-05	0.00431	CbGeAlD
Estradiol—AR—epithelium—breast cancer	8.16e-05	0.00431	CbGeAlD
Estradiol—ABCC10—female reproductive system—breast cancer	8.14e-05	0.0043	CbGeAlD
Estradiol—ESR1—epithelium—breast cancer	8.01e-05	0.00424	CbGeAlD
Estradiol—SHBG—bone marrow—breast cancer	7.97e-05	0.00422	CbGeAlD
Estradiol—ABCC10—adrenal gland—breast cancer	7.94e-05	0.0042	CbGeAlD
Estradiol—SLC22A1—adipose tissue—breast cancer	7.92e-05	0.00419	CbGeAlD
Estradiol—ESR2—female gonad—breast cancer	7.9e-05	0.00418	CbGeAlD
Estradiol—AR—skin of body—breast cancer	7.76e-05	0.0041	CbGeAlD
Estradiol—SHBG—female gonad—breast cancer	7.68e-05	0.00406	CbGeAlD
Estradiol—ABCC10—bone marrow—breast cancer	7.68e-05	0.00406	CbGeAlD
Estradiol—SLCO2B1—female reproductive system—breast cancer	7.62e-05	0.00403	CbGeAlD
Estradiol—AOX1—female gonad—breast cancer	7.61e-05	0.00402	CbGeAlD
Estradiol—SLC22A3—adipose tissue—breast cancer	7.57e-05	0.00401	CbGeAlD
Estradiol—SLCO2B1—adrenal gland—breast cancer	7.44e-05	0.00393	CbGeAlD
Estradiol—ABCC10—female gonad—breast cancer	7.4e-05	0.00392	CbGeAlD
Estradiol—ESR2—endocrine gland—breast cancer	7.35e-05	0.00389	CbGeAlD
Estradiol—AR—endometrium—breast cancer	7.32e-05	0.00387	CbGeAlD
Estradiol—SLCO1B1—endocrine gland—breast cancer	7.29e-05	0.00386	CbGeAlD
Estradiol—ESR1—endometrium—breast cancer	7.18e-05	0.0038	CbGeAlD
Estradiol—SLCO1C1—lymph node—breast cancer	7.15e-05	0.00378	CbGeAlD
Estradiol—SHBG—endocrine gland—breast cancer	7.15e-05	0.00378	CbGeAlD
Estradiol—CYP1B1—uterus—breast cancer	7.12e-05	0.00376	CbGeAlD
Estradiol—AOX1—endocrine gland—breast cancer	7.07e-05	0.00374	CbGeAlD
Estradiol—CYP1B1—pituitary gland—breast cancer	6.99e-05	0.0037	CbGeAlD
Estradiol—SLC22A3—female reproductive system—breast cancer	6.96e-05	0.00368	CbGeAlD
Estradiol—CYP1B1—adipose tissue—breast cancer	6.96e-05	0.00368	CbGeAlD
Estradiol—SLCO2B1—female gonad—breast cancer	6.94e-05	0.00367	CbGeAlD
Estradiol—ABCC10—endocrine gland—breast cancer	6.89e-05	0.00364	CbGeAlD
Estradiol—ALB—adrenal gland—breast cancer	6.8e-05	0.0036	CbGeAlD
Estradiol—SLC22A3—adrenal gland—breast cancer	6.79e-05	0.00359	CbGeAlD
Estradiol—AR—uterus—breast cancer	6.74e-05	0.00357	CbGeAlD
Estradiol—AR—pituitary gland—breast cancer	6.62e-05	0.0035	CbGeAlD
Estradiol—ESR1—uterus—breast cancer	6.62e-05	0.0035	CbGeAlD
Estradiol—AR—adipose tissue—breast cancer	6.59e-05	0.00349	CbGeAlD
Estradiol—ESR1—pituitary gland—breast cancer	6.5e-05	0.00344	CbGeAlD
Estradiol—ESR1—adipose tissue—breast cancer	6.47e-05	0.00342	CbGeAlD
Estradiol—SLCO2B1—endocrine gland—breast cancer	6.45e-05	0.00341	CbGeAlD
Estradiol—CYP1B1—female reproductive system—breast cancer	6.4e-05	0.00338	CbGeAlD
Estradiol—Equilin—SHBG—breast cancer	6.35e-05	0.0365	CrCbGaD
Estradiol—SLC22A3—female gonad—breast cancer	6.33e-05	0.00335	CbGeAlD
Estradiol—CYP1B1—adrenal gland—breast cancer	6.24e-05	0.0033	CbGeAlD
Estradiol—SLC22A1—endocrine gland—breast cancer	6.16e-05	0.00326	CbGeAlD
Estradiol—CYP1A1—epithelium—breast cancer	6.09e-05	0.00322	CbGeAlD
Estradiol—AR—female reproductive system—breast cancer	6.06e-05	0.0032	CbGeAlD
Estradiol—Fulvestrant—ESR1—breast cancer	6.02e-05	0.0346	CrCbGaD
Estradiol—ESR1—female reproductive system—breast cancer	5.95e-05	0.00315	CbGeAlD
Estradiol—SLCO1A2—endocrine gland—breast cancer	5.94e-05	0.00314	CbGeAlD
Estradiol—CYP2C8—endometrium—breast cancer	5.92e-05	0.00313	CbGeAlD
Estradiol—AR—adrenal gland—breast cancer	5.91e-05	0.00313	CbGeAlD
Estradiol—SLC22A3—endocrine gland—breast cancer	5.89e-05	0.00312	CbGeAlD
Estradiol—CYP1B1—female gonad—breast cancer	5.82e-05	0.00308	CbGeAlD
Estradiol—ESR1—adrenal gland—breast cancer	5.81e-05	0.00307	CbGeAlD
Estradiol—CYP1A1—skin of body—breast cancer	5.79e-05	0.00306	CbGeAlD
Estradiol—ABCG2—endometrium—breast cancer	5.75e-05	0.00304	CbGeAlD
Estradiol—SLCO4A1—lymph node—breast cancer	5.73e-05	0.00303	CbGeAlD
Estradiol—AR—female gonad—breast cancer	5.51e-05	0.00292	CbGeAlD
Estradiol—CYP1B1—endocrine gland—breast cancer	5.41e-05	0.00286	CbGeAlD
Estradiol—ESR1—female gonad—breast cancer	5.41e-05	0.00286	CbGeAlD
Estradiol—CYP2C8—pituitary gland—breast cancer	5.35e-05	0.00283	CbGeAlD
Estradiol—ABCG2—uterus—breast cancer	5.3e-05	0.0028	CbGeAlD
Estradiol—ABCG2—pituitary gland—breast cancer	5.2e-05	0.00275	CbGeAlD
Estradiol—ABCG2—adipose tissue—breast cancer	5.18e-05	0.00274	CbGeAlD
Estradiol—AR—endocrine gland—breast cancer	5.13e-05	0.00271	CbGeAlD
Estradiol—ESR2—lymph node—breast cancer	5.08e-05	0.00269	CbGeAlD
Estradiol—ESR1—endocrine gland—breast cancer	5.03e-05	0.00266	CbGeAlD
Estradiol—CYP1A1—uterus—breast cancer	5.03e-05	0.00266	CbGeAlD
Estradiol—Trilostane—ESR2—breast cancer	5.01e-05	0.0287	CrCbGaD
Estradiol—CYP1A1—adipose tissue—breast cancer	4.92e-05	0.0026	CbGeAlD
Estradiol—CYP2C8—female reproductive system—breast cancer	4.9e-05	0.00259	CbGeAlD
Estradiol—AOX1—lymph node—breast cancer	4.89e-05	0.00259	CbGeAlD
Estradiol—CYP3A5—adipose tissue—breast cancer	4.81e-05	0.00254	CbGeAlD
Estradiol—ABCC10—lymph node—breast cancer	4.76e-05	0.00252	CbGeAlD
Estradiol—CYP2C19—endocrine gland—breast cancer	4.75e-05	0.00251	CbGeAlD
Estradiol—ABCG2—adrenal gland—breast cancer	4.65e-05	0.00246	CbGeAlD
Estradiol—CYP1A1—female reproductive system—breast cancer	4.52e-05	0.00239	CbGeAlD
Estradiol—ABCG2—bone marrow—breast cancer	4.5e-05	0.00238	CbGeAlD
Estradiol—SLCO2B1—lymph node—breast cancer	4.46e-05	0.00236	CbGeAlD
Estradiol—Estriol—ESR2—breast cancer	4.37e-05	0.0251	CrCbGaD
Estradiol—Drostanolone—SHBG—breast cancer	4.36e-05	0.025	CrCbGaD
Estradiol—CYP2C9—female reproductive system—breast cancer	4.35e-05	0.0023	CbGeAlD
Estradiol—ABCG2—female gonad—breast cancer	4.34e-05	0.00229	CbGeAlD
Estradiol—CYP2C8—endocrine gland—breast cancer	4.15e-05	0.00219	CbGeAlD
Estradiol—CYP1A1—female gonad—breast cancer	4.12e-05	0.00218	CbGeAlD
Estradiol—ALB—lymph node—breast cancer	4.08e-05	0.00216	CbGeAlD
Estradiol—SLC22A3—lymph node—breast cancer	4.07e-05	0.00215	CbGeAlD
Estradiol—Quinestrol—ESR1—breast cancer	4.07e-05	0.0234	CrCbGaD
Estradiol—Estramustine—ESR2—breast cancer	4.06e-05	0.0233	CrCbGaD
Estradiol—CYP3A5—female gonad—breast cancer	4.02e-05	0.00213	CbGeAlD
Estradiol—Estriol—SHBG—breast cancer	3.98e-05	0.0229	CrCbGaD
Estradiol—CYP1A2—endocrine gland—breast cancer	3.88e-05	0.00205	CbGeAlD
Estradiol—ABCB1—embryo—breast cancer	3.88e-05	0.00205	CbGeAlD
Estradiol—CYP1A1—endocrine gland—breast cancer	3.83e-05	0.00202	CbGeAlD
Estradiol—Drostanolone—AR—breast cancer	3.82e-05	0.0219	CrCbGaD
Estradiol—CYP1B1—lymph node—breast cancer	3.74e-05	0.00198	CbGeAlD
Estradiol—CYP3A5—endocrine gland—breast cancer	3.74e-05	0.00198	CbGeAlD
Estradiol—CYP2C9—endocrine gland—breast cancer	3.68e-05	0.00195	CbGeAlD
Estradiol—AR—lymph node—breast cancer	3.54e-05	0.00187	CbGeAlD
Estradiol—ESR1—lymph node—breast cancer	3.48e-05	0.00184	CbGeAlD
Estradiol—Estropipate—ESR2—breast cancer	3.34e-05	0.0192	CrCbGaD
Estradiol—CYP3A4—female reproductive system—breast cancer	3.32e-05	0.00176	CbGeAlD
Estradiol—Drostanolone—CYP19A1—breast cancer	3.2e-05	0.0183	CrCbGaD
Estradiol—ABCB1—epithelium—breast cancer	3.16e-05	0.00167	CbGeAlD
Estradiol—Trilostane—ESR1—breast cancer	3.08e-05	0.0177	CrCbGaD
Estradiol—Mestranol—ESR1—breast cancer	3.08e-05	0.0177	CrCbGaD
Estradiol—Fulvestrant—CYP3A4—breast cancer	3.07e-05	0.0176	CrCbGaD
Estradiol—Estradiol valerate/Dienogest—CYP3A4—breast cancer	3.07e-05	0.0176	CrCbGaD
Estradiol—Estropipate—SHBG—breast cancer	3.05e-05	0.0175	CrCbGaD
Estradiol—Conjugated Estrogens—SLCO1B1—breast cancer	3.01e-05	0.0173	CrCbGaD
Estradiol—Estrone—SLCO1B1—breast cancer	3e-05	0.0172	CrCbGaD
Estradiol—ABCB1—endometrium—breast cancer	2.84e-05	0.0015	CbGeAlD
Estradiol—CYP3A4—endocrine gland—breast cancer	2.81e-05	0.00149	CbGeAlD
Estradiol—ABCG2—lymph node—breast cancer	2.79e-05	0.00147	CbGeAlD
Estradiol—Estriol—ESR1—breast cancer	2.69e-05	0.0154	CrCbGaD
Estradiol—CYP1A1—lymph node—breast cancer	2.65e-05	0.0014	CbGeAlD
Estradiol—ABCB1—uterus—breast cancer	2.61e-05	0.00138	CbGeAlD
Estradiol—ABCB1—pituitary gland—breast cancer	2.57e-05	0.00136	CbGeAlD
Estradiol—ABCB1—adipose tissue—breast cancer	2.56e-05	0.00135	CbGeAlD
Estradiol—Estramustine—ESR1—breast cancer	2.5e-05	0.0144	CrCbGaD
Estradiol—Conjugated Estrogens—ABCC1—breast cancer	2.49e-05	0.0143	CrCbGaD
Estradiol—Ethinyl Estradiol—ESR2—breast cancer	2.39e-05	0.0137	CrCbGaD
Estradiol—ABCB1—female reproductive system—breast cancer	2.35e-05	0.00124	CbGeAlD
Estradiol—ABCB1—adrenal gland—breast cancer	2.29e-05	0.00121	CbGeAlD
Estradiol—Conjugated Estrogens—COMT—breast cancer	2.24e-05	0.0128	CrCbGaD
Estradiol—ABCB1—bone marrow—breast cancer	2.22e-05	0.00117	CbGeAlD
Estradiol—Ethinyl Estradiol—SHBG—breast cancer	2.18e-05	0.0125	CrCbGaD
Estradiol—ABCB1—female gonad—breast cancer	2.14e-05	0.00113	CbGeAlD
Estradiol—Conjugated Estrogens—ESR2—breast cancer	2.08e-05	0.012	CrCbGaD
Estradiol—Estrone—ESR2—breast cancer	2.08e-05	0.0119	CrCbGaD
Estradiol—Estropipate—ESR1—breast cancer	2.06e-05	0.0118	CrCbGaD
Estradiol—ABCB1—endocrine gland—breast cancer	1.99e-05	0.00105	CbGeAlD
Estradiol—Estrone—SHBG—breast cancer	1.9e-05	0.0109	CrCbGaD
Estradiol—Estrone—CYP1B1—breast cancer	1.9e-05	0.0109	CrCbGaD
Estradiol—Ethinyl Estradiol—ESR1—breast cancer	1.47e-05	0.00844	CrCbGaD
Estradiol—ABCB1—lymph node—breast cancer	1.37e-05	0.000727	CbGeAlD
Estradiol—Conjugated Estrogens—ABCG2—breast cancer	1.31e-05	0.00752	CrCbGaD
Estradiol—Estrone—ABCG2—breast cancer	1.31e-05	0.0075	CrCbGaD
Estradiol—Conjugated Estrogens—ESR1—breast cancer	1.28e-05	0.00737	CrCbGaD
Estradiol—Estrone—ESR1—breast cancer	1.28e-05	0.00735	CrCbGaD
Estradiol—Estramustine—CYP3A4—breast cancer	1.28e-05	0.00733	CrCbGaD
Estradiol—Testosterone—SHBG—breast cancer	1.15e-05	0.00662	CrCbGaD
Estradiol—Testosterone—CYP1B1—breast cancer	1.15e-05	0.00662	CrCbGaD
Estradiol—Estriol—ABCB1—breast cancer	1.14e-05	0.00656	CrCbGaD
Estradiol—Estramustine—ABCB1—breast cancer	1.06e-05	0.0061	CrCbGaD
Estradiol—Estropipate—CYP3A4—breast cancer	1.05e-05	0.00603	CrCbGaD
Estradiol—Estrone—CYP1A1—breast cancer	1.02e-05	0.00588	CrCbGaD
Estradiol—Testosterone—AR—breast cancer	1.01e-05	0.0058	CrCbGaD
Estradiol—Estropipate—ALB—breast cancer	9.16e-06	0.00526	CrCbGaD
Estradiol—Testosterone—CYP19A1—breast cancer	8.46e-06	0.00486	CrCbGaD
Estradiol—Testosterone—ABCG2—breast cancer	7.95e-06	0.00456	CrCbGaD
Estradiol—Ethinyl Estradiol—CYP3A4—breast cancer	7.5e-06	0.00431	CrCbGaD
Estradiol—Conjugated Estrogens—CYP3A4—breast cancer	6.55e-06	0.00376	CrCbGaD
Estradiol—Estrone—CYP3A4—breast cancer	6.53e-06	0.00375	CrCbGaD
Estradiol—Ethinyl Estradiol—ABCB1—breast cancer	6.24e-06	0.00358	CrCbGaD
Estradiol—Testosterone—CYP1A1—breast cancer	6.22e-06	0.00357	CrCbGaD
Estradiol—Estrone—ALB—breast cancer	5.7e-06	0.00327	CrCbGaD
Estradiol—Conjugated Estrogens—ABCB1—breast cancer	5.46e-06	0.00313	CrCbGaD
Estradiol—Estrone—ABCB1—breast cancer	5.44e-06	0.00312	CrCbGaD
Estradiol—Flushing—Epirubicin—breast cancer	4.66e-06	7.6e-05	CcSEcCtD
Estradiol—Vomiting—Fluorouracil—breast cancer	4.66e-06	7.6e-05	CcSEcCtD
Estradiol—Rhinitis—Doxorubicin—breast cancer	4.65e-06	7.6e-05	CcSEcCtD
Estradiol—Dyspepsia—Docetaxel—breast cancer	4.65e-06	7.6e-05	CcSEcCtD
Estradiol—Haemorrhage—Doxorubicin—breast cancer	4.64e-06	7.58e-05	CcSEcCtD
Estradiol—Hepatitis—Doxorubicin—breast cancer	4.64e-06	7.58e-05	CcSEcCtD
Estradiol—Insomnia—Capecitabine—breast cancer	4.63e-06	7.56e-05	CcSEcCtD
Estradiol—Hypoaesthesia—Doxorubicin—breast cancer	4.62e-06	7.54e-05	CcSEcCtD
Estradiol—Rash—Fluorouracil—breast cancer	4.62e-06	7.54e-05	CcSEcCtD
Estradiol—Dermatitis—Fluorouracil—breast cancer	4.61e-06	7.53e-05	CcSEcCtD
Estradiol—Pharyngitis—Doxorubicin—breast cancer	4.61e-06	7.52e-05	CcSEcCtD
Estradiol—Paraesthesia—Capecitabine—breast cancer	4.59e-06	7.5e-05	CcSEcCtD
Estradiol—Decreased appetite—Docetaxel—breast cancer	4.59e-06	7.5e-05	CcSEcCtD
Estradiol—Hypersensitivity—Paclitaxel—breast cancer	4.59e-06	7.5e-05	CcSEcCtD
Estradiol—Headache—Fluorouracil—breast cancer	4.59e-06	7.49e-05	CcSEcCtD
Estradiol—Urinary tract disorder—Doxorubicin—breast cancer	4.58e-06	7.49e-05	CcSEcCtD
Estradiol—Oedema peripheral—Doxorubicin—breast cancer	4.57e-06	7.47e-05	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—breast cancer	4.57e-06	7.46e-05	CcSEcCtD
Estradiol—Gastrointestinal disorder—Docetaxel—breast cancer	4.56e-06	7.45e-05	CcSEcCtD
Estradiol—Connective tissue disorder—Doxorubicin—breast cancer	4.56e-06	7.45e-05	CcSEcCtD
Estradiol—Dyspnoea—Capecitabine—breast cancer	4.56e-06	7.45e-05	CcSEcCtD
Estradiol—Fatigue—Docetaxel—breast cancer	4.56e-06	7.44e-05	CcSEcCtD
Estradiol—Angiopathy—Epirubicin—breast cancer	4.55e-06	7.43e-05	CcSEcCtD
Estradiol—Urethral disorder—Doxorubicin—breast cancer	4.55e-06	7.43e-05	CcSEcCtD
Estradiol—Nausea—Irinotecan—breast cancer	4.54e-06	7.41e-05	CcSEcCtD
Estradiol—Nausea—Mitoxantrone—breast cancer	4.54e-06	7.41e-05	CcSEcCtD
Estradiol—Immune system disorder—Epirubicin—breast cancer	4.53e-06	7.4e-05	CcSEcCtD
Estradiol—Mediastinal disorder—Epirubicin—breast cancer	4.52e-06	7.38e-05	CcSEcCtD
Estradiol—Pain—Docetaxel—breast cancer	4.52e-06	7.38e-05	CcSEcCtD
Estradiol—Constipation—Docetaxel—breast cancer	4.52e-06	7.38e-05	CcSEcCtD
Estradiol—Back pain—Methotrexate—breast cancer	4.51e-06	7.37e-05	CcSEcCtD
Estradiol—Dyspepsia—Capecitabine—breast cancer	4.5e-06	7.35e-05	CcSEcCtD
Estradiol—Chills—Epirubicin—breast cancer	4.5e-06	7.35e-05	CcSEcCtD
Estradiol—Visual impairment—Doxorubicin—breast cancer	4.47e-06	7.3e-05	CcSEcCtD
Estradiol—Asthenia—Paclitaxel—breast cancer	4.47e-06	7.3e-05	CcSEcCtD
Estradiol—Decreased appetite—Capecitabine—breast cancer	4.45e-06	7.26e-05	CcSEcCtD
Estradiol—Alopecia—Epirubicin—breast cancer	4.43e-06	7.24e-05	CcSEcCtD
Estradiol—Nausea—Gemcitabine—breast cancer	4.42e-06	7.22e-05	CcSEcCtD
Estradiol—Gastrointestinal disorder—Capecitabine—breast cancer	4.42e-06	7.21e-05	CcSEcCtD
Estradiol—Fatigue—Capecitabine—breast cancer	4.41e-06	7.2e-05	CcSEcCtD
Estradiol—Pruritus—Paclitaxel—breast cancer	4.41e-06	7.2e-05	CcSEcCtD
Estradiol—Mental disorder—Epirubicin—breast cancer	4.4e-06	7.18e-05	CcSEcCtD
Estradiol—Erythema multiforme—Doxorubicin—breast cancer	4.39e-06	7.17e-05	CcSEcCtD
Estradiol—Pain—Capecitabine—breast cancer	4.38e-06	7.14e-05	CcSEcCtD
Estradiol—Constipation—Capecitabine—breast cancer	4.38e-06	7.14e-05	CcSEcCtD
Estradiol—Malnutrition—Epirubicin—breast cancer	4.37e-06	7.13e-05	CcSEcCtD
Estradiol—Erythema—Epirubicin—breast cancer	4.37e-06	7.13e-05	CcSEcCtD
Estradiol—Feeling abnormal—Docetaxel—breast cancer	4.36e-06	7.11e-05	CcSEcCtD
Estradiol—Nausea—Fluorouracil—breast cancer	4.35e-06	7.1e-05	CcSEcCtD
Estradiol—Eye disorder—Doxorubicin—breast cancer	4.34e-06	7.08e-05	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—breast cancer	4.33e-06	7.07e-05	CcSEcCtD
Estradiol—Tinnitus—Doxorubicin—breast cancer	4.33e-06	7.07e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Docetaxel—breast cancer	4.32e-06	7.06e-05	CcSEcCtD
Estradiol—Flushing—Doxorubicin—breast cancer	4.31e-06	7.03e-05	CcSEcCtD
Estradiol—Cardiac disorder—Doxorubicin—breast cancer	4.31e-06	7.03e-05	CcSEcCtD
Estradiol—Flatulence—Epirubicin—breast cancer	4.3e-06	7.03e-05	CcSEcCtD
Estradiol—Tension—Epirubicin—breast cancer	4.29e-06	7e-05	CcSEcCtD
Estradiol—Dysgeusia—Epirubicin—breast cancer	4.28e-06	6.98e-05	CcSEcCtD
Estradiol—Diarrhoea—Paclitaxel—breast cancer	4.27e-06	6.97e-05	CcSEcCtD
Estradiol—Nervousness—Epirubicin—breast cancer	4.24e-06	6.93e-05	CcSEcCtD
Estradiol—Back pain—Epirubicin—breast cancer	4.22e-06	6.9e-05	CcSEcCtD
Estradiol—Feeling abnormal—Capecitabine—breast cancer	4.22e-06	6.88e-05	CcSEcCtD
Estradiol—Angiopathy—Doxorubicin—breast cancer	4.21e-06	6.88e-05	CcSEcCtD
Estradiol—Malaise—Methotrexate—breast cancer	4.21e-06	6.87e-05	CcSEcCtD
Estradiol—Muscle spasms—Epirubicin—breast cancer	4.2e-06	6.86e-05	CcSEcCtD
Estradiol—Immune system disorder—Doxorubicin—breast cancer	4.19e-06	6.85e-05	CcSEcCtD
Estradiol—Vertigo—Methotrexate—breast cancer	4.19e-06	6.85e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Capecitabine—breast cancer	4.18e-06	6.83e-05	CcSEcCtD
Estradiol—Mediastinal disorder—Doxorubicin—breast cancer	4.18e-06	6.83e-05	CcSEcCtD
Estradiol—Abdominal pain—Docetaxel—breast cancer	4.18e-06	6.82e-05	CcSEcCtD
Estradiol—Body temperature increased—Docetaxel—breast cancer	4.18e-06	6.82e-05	CcSEcCtD
Estradiol—Chills—Doxorubicin—breast cancer	4.17e-06	6.8e-05	CcSEcCtD
Estradiol—Dizziness—Paclitaxel—breast cancer	4.12e-06	6.73e-05	CcSEcCtD
Estradiol—Alopecia—Doxorubicin—breast cancer	4.1e-06	6.7e-05	CcSEcCtD
Estradiol—Cough—Methotrexate—breast cancer	4.07e-06	6.65e-05	CcSEcCtD
Estradiol—Mental disorder—Doxorubicin—breast cancer	4.07e-06	6.64e-05	CcSEcCtD
Estradiol—Urticaria—Capecitabine—breast cancer	4.06e-06	6.64e-05	CcSEcCtD
Estradiol—Ill-defined disorder—Epirubicin—breast cancer	4.05e-06	6.62e-05	CcSEcCtD
Estradiol—Body temperature increased—Capecitabine—breast cancer	4.04e-06	6.6e-05	CcSEcCtD
Estradiol—Abdominal pain—Capecitabine—breast cancer	4.04e-06	6.6e-05	CcSEcCtD
Estradiol—Erythema—Doxorubicin—breast cancer	4.04e-06	6.6e-05	CcSEcCtD
Estradiol—Malnutrition—Doxorubicin—breast cancer	4.04e-06	6.6e-05	CcSEcCtD
Estradiol—Agitation—Epirubicin—breast cancer	4.01e-06	6.55e-05	CcSEcCtD
Estradiol—Flatulence—Doxorubicin—breast cancer	3.98e-06	6.5e-05	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—breast cancer	3.97e-06	6.49e-05	CcSEcCtD
Estradiol—Myalgia—Methotrexate—breast cancer	3.97e-06	6.49e-05	CcSEcCtD
Estradiol—Chest pain—Methotrexate—breast cancer	3.97e-06	6.49e-05	CcSEcCtD
Estradiol—Testosterone—CYP3A4—breast cancer	3.97e-06	0.00228	CrCbGaD
Estradiol—Tension—Doxorubicin—breast cancer	3.97e-06	6.47e-05	CcSEcCtD
Estradiol—Vomiting—Paclitaxel—breast cancer	3.96e-06	6.47e-05	CcSEcCtD
Estradiol—Dysgeusia—Doxorubicin—breast cancer	3.96e-06	6.46e-05	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.95e-06	6.44e-05	CcSEcCtD
Estradiol—Malaise—Epirubicin—breast cancer	3.94e-06	6.43e-05	CcSEcCtD
Estradiol—Rash—Paclitaxel—breast cancer	3.93e-06	6.42e-05	CcSEcCtD
Estradiol—Dermatitis—Paclitaxel—breast cancer	3.93e-06	6.41e-05	CcSEcCtD
Estradiol—Discomfort—Methotrexate—breast cancer	3.93e-06	6.41e-05	CcSEcCtD
Estradiol—Nervousness—Doxorubicin—breast cancer	3.93e-06	6.41e-05	CcSEcCtD
Estradiol—Vertigo—Epirubicin—breast cancer	3.92e-06	6.41e-05	CcSEcCtD
Estradiol—Syncope—Epirubicin—breast cancer	3.92e-06	6.39e-05	CcSEcCtD
Estradiol—Back pain—Doxorubicin—breast cancer	3.91e-06	6.38e-05	CcSEcCtD
Estradiol—Headache—Paclitaxel—breast cancer	3.91e-06	6.38e-05	CcSEcCtD
Estradiol—Hypersensitivity—Docetaxel—breast cancer	3.89e-06	6.36e-05	CcSEcCtD
Estradiol—Muscle spasms—Doxorubicin—breast cancer	3.89e-06	6.34e-05	CcSEcCtD
Estradiol—Palpitations—Epirubicin—breast cancer	3.86e-06	6.3e-05	CcSEcCtD
Estradiol—Confusional state—Methotrexate—breast cancer	3.84e-06	6.27e-05	CcSEcCtD
Estradiol—Loss of consciousness—Epirubicin—breast cancer	3.84e-06	6.27e-05	CcSEcCtD
Estradiol—Cough—Epirubicin—breast cancer	3.81e-06	6.22e-05	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—breast cancer	3.81e-06	6.22e-05	CcSEcCtD
Estradiol—Asthenia—Docetaxel—breast cancer	3.79e-06	6.19e-05	CcSEcCtD
Estradiol—Infection—Methotrexate—breast cancer	3.78e-06	6.18e-05	CcSEcCtD
Estradiol—Hypertension—Epirubicin—breast cancer	3.77e-06	6.16e-05	CcSEcCtD
Estradiol—Hypersensitivity—Capecitabine—breast cancer	3.77e-06	6.15e-05	CcSEcCtD
Estradiol—Ill-defined disorder—Doxorubicin—breast cancer	3.75e-06	6.12e-05	CcSEcCtD
Estradiol—Pruritus—Docetaxel—breast cancer	3.74e-06	6.1e-05	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—breast cancer	3.74e-06	6.1e-05	CcSEcCtD
Estradiol—Arthralgia—Epirubicin—breast cancer	3.72e-06	6.07e-05	CcSEcCtD
Estradiol—Myalgia—Epirubicin—breast cancer	3.72e-06	6.07e-05	CcSEcCtD
Estradiol—Chest pain—Epirubicin—breast cancer	3.72e-06	6.07e-05	CcSEcCtD
Estradiol—Agitation—Doxorubicin—breast cancer	3.71e-06	6.06e-05	CcSEcCtD
Estradiol—Anxiety—Epirubicin—breast cancer	3.71e-06	6.05e-05	CcSEcCtD
Estradiol—Nausea—Paclitaxel—breast cancer	3.7e-06	6.05e-05	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—breast cancer	3.7e-06	6.04e-05	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.69e-06	6.03e-05	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—breast cancer	3.68e-06	6.01e-05	CcSEcCtD
Estradiol—Discomfort—Epirubicin—breast cancer	3.67e-06	6e-05	CcSEcCtD
Estradiol—Asthenia—Capecitabine—breast cancer	3.67e-06	5.99e-05	CcSEcCtD
Estradiol—Malaise—Doxorubicin—breast cancer	3.64e-06	5.95e-05	CcSEcCtD
Estradiol—Dry mouth—Epirubicin—breast cancer	3.64e-06	5.94e-05	CcSEcCtD
Estradiol—Vertigo—Doxorubicin—breast cancer	3.63e-06	5.93e-05	CcSEcCtD
Estradiol—Syncope—Doxorubicin—breast cancer	3.62e-06	5.92e-05	CcSEcCtD
Estradiol—Pruritus—Capecitabine—breast cancer	3.62e-06	5.91e-05	CcSEcCtD
Estradiol—Diarrhoea—Docetaxel—breast cancer	3.62e-06	5.9e-05	CcSEcCtD
Estradiol—Confusional state—Epirubicin—breast cancer	3.59e-06	5.87e-05	CcSEcCtD
Estradiol—Palpitations—Doxorubicin—breast cancer	3.57e-06	5.83e-05	CcSEcCtD
Estradiol—Oedema—Epirubicin—breast cancer	3.56e-06	5.82e-05	CcSEcCtD
Estradiol—Anaphylactic shock—Epirubicin—breast cancer	3.56e-06	5.82e-05	CcSEcCtD
Estradiol—Loss of consciousness—Doxorubicin—breast cancer	3.55e-06	5.8e-05	CcSEcCtD
Estradiol—Infection—Epirubicin—breast cancer	3.54e-06	5.78e-05	CcSEcCtD
Estradiol—Cough—Doxorubicin—breast cancer	3.53e-06	5.76e-05	CcSEcCtD
Estradiol—Shock—Epirubicin—breast cancer	3.51e-06	5.73e-05	CcSEcCtD
Estradiol—Diarrhoea—Capecitabine—breast cancer	3.5e-06	5.72e-05	CcSEcCtD
Estradiol—Nervous system disorder—Epirubicin—breast cancer	3.5e-06	5.71e-05	CcSEcCtD
Estradiol—Dizziness—Docetaxel—breast cancer	3.49e-06	5.71e-05	CcSEcCtD
Estradiol—Hypertension—Doxorubicin—breast cancer	3.49e-06	5.7e-05	CcSEcCtD
Estradiol—Tachycardia—Epirubicin—breast cancer	3.48e-06	5.68e-05	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—breast cancer	3.47e-06	5.67e-05	CcSEcCtD
Estradiol—Testosterone—ALB—breast cancer	3.47e-06	0.00199	CrCbGaD
Estradiol—Skin disorder—Epirubicin—breast cancer	3.46e-06	5.65e-05	CcSEcCtD
Estradiol—Hyperhidrosis—Epirubicin—breast cancer	3.45e-06	5.63e-05	CcSEcCtD
Estradiol—Insomnia—Methotrexate—breast cancer	3.45e-06	5.62e-05	CcSEcCtD
Estradiol—Chest pain—Doxorubicin—breast cancer	3.44e-06	5.62e-05	CcSEcCtD
Estradiol—Myalgia—Doxorubicin—breast cancer	3.44e-06	5.62e-05	CcSEcCtD
Estradiol—Arthralgia—Doxorubicin—breast cancer	3.44e-06	5.62e-05	CcSEcCtD
Estradiol—Anxiety—Doxorubicin—breast cancer	3.43e-06	5.6e-05	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—breast cancer	3.42e-06	5.58e-05	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.42e-06	5.58e-05	CcSEcCtD
Estradiol—Discomfort—Doxorubicin—breast cancer	3.4e-06	5.55e-05	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—breast cancer	3.4e-06	5.54e-05	CcSEcCtD
Estradiol—Somnolence—Methotrexate—breast cancer	3.39e-06	5.53e-05	CcSEcCtD
Estradiol—Dizziness—Capecitabine—breast cancer	3.38e-06	5.52e-05	CcSEcCtD
Estradiol—Dry mouth—Doxorubicin—breast cancer	3.36e-06	5.49e-05	CcSEcCtD
Estradiol—Vomiting—Docetaxel—breast cancer	3.36e-06	5.49e-05	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—breast cancer	3.35e-06	5.47e-05	CcSEcCtD
Estradiol—Rash—Docetaxel—breast cancer	3.33e-06	5.44e-05	CcSEcCtD
Estradiol—Dermatitis—Docetaxel—breast cancer	3.33e-06	5.44e-05	CcSEcCtD
Estradiol—Confusional state—Doxorubicin—breast cancer	3.33e-06	5.43e-05	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—breast cancer	3.31e-06	5.41e-05	CcSEcCtD
Estradiol—Headache—Docetaxel—breast cancer	3.31e-06	5.41e-05	CcSEcCtD
Estradiol—Testosterone—ABCB1—breast cancer	3.31e-06	0.0019	CrCbGaD
Estradiol—Anaphylactic shock—Doxorubicin—breast cancer	3.3e-06	5.38e-05	CcSEcCtD
Estradiol—Oedema—Doxorubicin—breast cancer	3.3e-06	5.38e-05	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—breast cancer	3.29e-06	5.37e-05	CcSEcCtD
Estradiol—Fatigue—Methotrexate—breast cancer	3.28e-06	5.36e-05	CcSEcCtD
Estradiol—Infection—Doxorubicin—breast cancer	3.28e-06	5.35e-05	CcSEcCtD
Estradiol—Pain—Methotrexate—breast cancer	3.26e-06	5.32e-05	CcSEcCtD
Estradiol—Vomiting—Capecitabine—breast cancer	3.25e-06	5.31e-05	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Epirubicin—breast cancer	3.25e-06	5.3e-05	CcSEcCtD
Estradiol—Shock—Doxorubicin—breast cancer	3.24e-06	5.3e-05	CcSEcCtD
Estradiol—Nervous system disorder—Doxorubicin—breast cancer	3.23e-06	5.28e-05	CcSEcCtD
Estradiol—Rash—Capecitabine—breast cancer	3.23e-06	5.27e-05	CcSEcCtD
Estradiol—Insomnia—Epirubicin—breast cancer	3.22e-06	5.26e-05	CcSEcCtD
Estradiol—Dermatitis—Capecitabine—breast cancer	3.22e-06	5.26e-05	CcSEcCtD
Estradiol—Tachycardia—Doxorubicin—breast cancer	3.22e-06	5.26e-05	CcSEcCtD
Estradiol—Headache—Capecitabine—breast cancer	3.21e-06	5.23e-05	CcSEcCtD
Estradiol—Skin disorder—Doxorubicin—breast cancer	3.2e-06	5.23e-05	CcSEcCtD
Estradiol—Paraesthesia—Epirubicin—breast cancer	3.2e-06	5.23e-05	CcSEcCtD
Estradiol—Hyperhidrosis—Doxorubicin—breast cancer	3.19e-06	5.21e-05	CcSEcCtD
Estradiol—Dyspnoea—Epirubicin—breast cancer	3.18e-06	5.19e-05	CcSEcCtD
Estradiol—Somnolence—Epirubicin—breast cancer	3.17e-06	5.17e-05	CcSEcCtD
Estradiol—Nausea—Docetaxel—breast cancer	3.14e-06	5.13e-05	CcSEcCtD
Estradiol—Feeling abnormal—Methotrexate—breast cancer	3.14e-06	5.12e-05	CcSEcCtD
Estradiol—Dyspepsia—Epirubicin—breast cancer	3.14e-06	5.12e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—breast cancer	3.11e-06	5.09e-05	CcSEcCtD
Estradiol—Decreased appetite—Epirubicin—breast cancer	3.1e-06	5.06e-05	CcSEcCtD
Estradiol—Gastrointestinal disorder—Epirubicin—breast cancer	3.08e-06	5.02e-05	CcSEcCtD
Estradiol—Fatigue—Epirubicin—breast cancer	3.07e-06	5.02e-05	CcSEcCtD
Estradiol—Pain—Epirubicin—breast cancer	3.05e-06	4.98e-05	CcSEcCtD
Estradiol—Constipation—Epirubicin—breast cancer	3.05e-06	4.98e-05	CcSEcCtD
Estradiol—Nausea—Capecitabine—breast cancer	3.04e-06	4.96e-05	CcSEcCtD
Estradiol—Urticaria—Methotrexate—breast cancer	3.03e-06	4.94e-05	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—breast cancer	3.01e-06	4.92e-05	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—breast cancer	3.01e-06	4.92e-05	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.01e-06	4.91e-05	CcSEcCtD
Estradiol—Insomnia—Doxorubicin—breast cancer	2.98e-06	4.87e-05	CcSEcCtD
Estradiol—Paraesthesia—Doxorubicin—breast cancer	2.96e-06	4.84e-05	CcSEcCtD
Estradiol—Dyspnoea—Doxorubicin—breast cancer	2.94e-06	4.8e-05	CcSEcCtD
Estradiol—Feeling abnormal—Epirubicin—breast cancer	2.94e-06	4.8e-05	CcSEcCtD
Estradiol—Somnolence—Doxorubicin—breast cancer	2.93e-06	4.79e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Epirubicin—breast cancer	2.91e-06	4.76e-05	CcSEcCtD
Estradiol—Dyspepsia—Doxorubicin—breast cancer	2.9e-06	4.74e-05	CcSEcCtD
Estradiol—Decreased appetite—Doxorubicin—breast cancer	2.87e-06	4.68e-05	CcSEcCtD
Estradiol—Gastrointestinal disorder—Doxorubicin—breast cancer	2.85e-06	4.65e-05	CcSEcCtD
Estradiol—Fatigue—Doxorubicin—breast cancer	2.84e-06	4.64e-05	CcSEcCtD
Estradiol—Urticaria—Epirubicin—breast cancer	2.83e-06	4.62e-05	CcSEcCtD
Estradiol—Pain—Doxorubicin—breast cancer	2.82e-06	4.6e-05	CcSEcCtD
Estradiol—Constipation—Doxorubicin—breast cancer	2.82e-06	4.6e-05	CcSEcCtD
Estradiol—Abdominal pain—Epirubicin—breast cancer	2.82e-06	4.6e-05	CcSEcCtD
Estradiol—Body temperature increased—Epirubicin—breast cancer	2.82e-06	4.6e-05	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—breast cancer	2.81e-06	4.58e-05	CcSEcCtD
Estradiol—Asthenia—Methotrexate—breast cancer	2.73e-06	4.46e-05	CcSEcCtD
Estradiol—Feeling abnormal—Doxorubicin—breast cancer	2.72e-06	4.44e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Doxorubicin—breast cancer	2.7e-06	4.4e-05	CcSEcCtD
Estradiol—Pruritus—Methotrexate—breast cancer	2.69e-06	4.4e-05	CcSEcCtD
Estradiol—Hypersensitivity—Epirubicin—breast cancer	2.63e-06	4.29e-05	CcSEcCtD
Estradiol—Urticaria—Doxorubicin—breast cancer	2.62e-06	4.28e-05	CcSEcCtD
Estradiol—Abdominal pain—Doxorubicin—breast cancer	2.61e-06	4.26e-05	CcSEcCtD
Estradiol—Body temperature increased—Doxorubicin—breast cancer	2.61e-06	4.26e-05	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—breast cancer	2.61e-06	4.26e-05	CcSEcCtD
Estradiol—Asthenia—Epirubicin—breast cancer	2.56e-06	4.18e-05	CcSEcCtD
Estradiol—Pruritus—Epirubicin—breast cancer	2.52e-06	4.12e-05	CcSEcCtD
Estradiol—Dizziness—Methotrexate—breast cancer	2.52e-06	4.11e-05	CcSEcCtD
Estradiol—Diarrhoea—Epirubicin—breast cancer	2.44e-06	3.98e-05	CcSEcCtD
Estradiol—Hypersensitivity—Doxorubicin—breast cancer	2.43e-06	3.97e-05	CcSEcCtD
Estradiol—Vomiting—Methotrexate—breast cancer	2.42e-06	3.95e-05	CcSEcCtD
Estradiol—Rash—Methotrexate—breast cancer	2.4e-06	3.92e-05	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—breast cancer	2.4e-06	3.92e-05	CcSEcCtD
Estradiol—Headache—Methotrexate—breast cancer	2.39e-06	3.9e-05	CcSEcCtD
Estradiol—Asthenia—Doxorubicin—breast cancer	2.37e-06	3.86e-05	CcSEcCtD
Estradiol—Dizziness—Epirubicin—breast cancer	2.36e-06	3.85e-05	CcSEcCtD
Estradiol—Pruritus—Doxorubicin—breast cancer	2.33e-06	3.81e-05	CcSEcCtD
Estradiol—Vomiting—Epirubicin—breast cancer	2.27e-06	3.7e-05	CcSEcCtD
Estradiol—Nausea—Methotrexate—breast cancer	2.26e-06	3.69e-05	CcSEcCtD
Estradiol—Diarrhoea—Doxorubicin—breast cancer	2.26e-06	3.68e-05	CcSEcCtD
Estradiol—Rash—Epirubicin—breast cancer	2.25e-06	3.67e-05	CcSEcCtD
Estradiol—Dermatitis—Epirubicin—breast cancer	2.25e-06	3.67e-05	CcSEcCtD
Estradiol—Headache—Epirubicin—breast cancer	2.23e-06	3.65e-05	CcSEcCtD
Estradiol—Dizziness—Doxorubicin—breast cancer	2.18e-06	3.56e-05	CcSEcCtD
Estradiol—Nausea—Epirubicin—breast cancer	2.12e-06	3.46e-05	CcSEcCtD
Estradiol—Vomiting—Doxorubicin—breast cancer	2.1e-06	3.42e-05	CcSEcCtD
Estradiol—Rash—Doxorubicin—breast cancer	2.08e-06	3.4e-05	CcSEcCtD
Estradiol—Dermatitis—Doxorubicin—breast cancer	2.08e-06	3.39e-05	CcSEcCtD
Estradiol—Headache—Doxorubicin—breast cancer	2.07e-06	3.37e-05	CcSEcCtD
Estradiol—Nausea—Doxorubicin—breast cancer	1.96e-06	3.2e-05	CcSEcCtD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.68e-07	6.12e-06	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PIK3CA—breast cancer	2.68e-07	6.12e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NCOR1—breast cancer	2.67e-07	6.08e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.67e-07	6.08e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTM1—breast cancer	2.67e-07	6.08e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—COMT—breast cancer	2.66e-07	6.06e-06	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MAPK3—breast cancer	2.66e-07	6.06e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CAV1—breast cancer	2.66e-07	6.05e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SERPINE1—breast cancer	2.66e-07	6.05e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.66e-07	6.05e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CPT1A—breast cancer	2.65e-07	6.03e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ABCG2—breast cancer	2.65e-07	6.03e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—MTR—breast cancer	2.65e-07	6.03e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTP1—breast cancer	2.65e-07	6.03e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP3A4—breast cancer	2.64e-07	6.02e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—MTHFR—breast cancer	2.64e-07	6.02e-06	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PIK3CA—breast cancer	2.64e-07	6e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—TYMS—breast cancer	2.63e-07	6e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.63e-07	5.99e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—MTHFR—breast cancer	2.63e-07	5.98e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—HMOX1—breast cancer	2.61e-07	5.95e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ITPR1—breast cancer	2.6e-07	5.93e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTM1—breast cancer	2.6e-07	5.93e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PLA2G4A—breast cancer	2.6e-07	5.93e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NCOR1—breast cancer	2.6e-07	5.93e-06	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTEN—breast cancer	2.6e-07	5.93e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP1B1—breast cancer	2.6e-07	5.92e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—HPGDS—breast cancer	2.6e-07	5.91e-06	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MYC—breast cancer	2.59e-07	5.89e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—HBA1—breast cancer	2.58e-07	5.88e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CG—breast cancer	2.56e-07	5.84e-06	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTEN—breast cancer	2.56e-07	5.82e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GPX1—breast cancer	2.55e-07	5.82e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.55e-07	5.81e-06	CbGpPWpGaD
Estradiol—ALB—Hemostasis—PIK3CA—breast cancer	2.54e-07	5.79e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.54e-07	5.78e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NOS3—breast cancer	2.54e-07	5.78e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP1A1—breast cancer	2.53e-07	5.76e-06	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CB—breast cancer	2.53e-07	5.76e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTT1—breast cancer	2.52e-07	5.74e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ACHE—breast cancer	2.52e-07	5.74e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ERCC2—breast cancer	2.51e-07	5.71e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ABCB1—breast cancer	2.51e-07	5.71e-06	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTGS2—breast cancer	2.5e-07	5.7e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GPX1—breast cancer	2.49e-07	5.68e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NCOA1—breast cancer	2.48e-07	5.65e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP1A1—breast cancer	2.47e-07	5.62e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—TYMS—breast cancer	2.46e-07	5.6e-06	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—breast cancer	2.46e-07	5.6e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ERCC2—breast cancer	2.45e-07	5.58e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP19A1—breast cancer	2.44e-07	5.57e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—STK11—breast cancer	2.44e-07	5.57e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CAV1—breast cancer	2.44e-07	5.55e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.43e-07	5.54e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NCOR1—breast cancer	2.43e-07	5.54e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTM1—breast cancer	2.43e-07	5.54e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—CAV1—breast cancer	2.42e-07	5.52e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CG—breast cancer	2.42e-07	5.51e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MDM2—breast cancer	2.41e-07	5.48e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RAF1—breast cancer	2.4e-07	5.46e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RELA—breast cancer	2.39e-07	5.44e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP17A1—breast cancer	2.38e-07	5.43e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ERBB2—breast cancer	2.37e-07	5.4e-06	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTEN—breast cancer	2.37e-07	5.39e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ENO1—breast cancer	2.36e-07	5.37e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS1—breast cancer	2.36e-07	5.37e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—MTHFR—breast cancer	2.36e-07	5.37e-06	CbGpPWpGaD
Estradiol—ALB—Hemostasis—HRAS—breast cancer	2.35e-07	5.36e-06	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTEN—breast cancer	2.35e-07	5.35e-06	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTEN—breast cancer	2.34e-07	5.34e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MTOR—breast cancer	2.34e-07	5.33e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CB—breast cancer	2.34e-07	5.33e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GPX1—breast cancer	2.33e-07	5.31e-06	CbGpPWpGaD
Estradiol—AR—Gene Expression—AKT1—breast cancer	2.33e-07	5.3e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.33e-07	5.3e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.31e-07	5.27e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP2D6—breast cancer	2.31e-07	5.27e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP1A1—breast cancer	2.31e-07	5.25e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—MTHFR—breast cancer	2.3e-07	5.24e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.29e-07	5.23e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ERCC2—breast cancer	2.29e-07	5.21e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—COMT—breast cancer	2.27e-07	5.18e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NCOA2—breast cancer	2.27e-07	5.17e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTP1—breast cancer	2.26e-07	5.15e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CD—breast cancer	2.25e-07	5.13e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL8—breast cancer	2.25e-07	5.12e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—HMOX1—breast cancer	2.23e-07	5.08e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ITPR1—breast cancer	2.23e-07	5.07e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ALB—breast cancer	2.22e-07	5.06e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CG—breast cancer	2.22e-07	5.05e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CG—breast cancer	2.21e-07	5.03e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—FASN—breast cancer	2.2e-07	5.02e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN1B—breast cancer	2.2e-07	5e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—BCHE—breast cancer	2.19e-07	5e-06	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—AKT1—breast cancer	2.19e-07	5e-06	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTEN—breast cancer	2.18e-07	4.97e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CAV1—breast cancer	2.17e-07	4.95e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SLC5A5—breast cancer	2.17e-07	4.94e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CASP3—breast cancer	2.15e-07	4.9e-06	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—AKT1—breast cancer	2.15e-07	4.9e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2—breast cancer	2.15e-07	4.9e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—MTHFR—breast cancer	2.15e-07	4.9e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ABCB1—breast cancer	2.14e-07	4.88e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CD—breast cancer	2.13e-07	4.85e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—NOS3—breast cancer	2.13e-07	4.84e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CAV1—breast cancer	2.12e-07	4.83e-06	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CA—breast cancer	2.11e-07	4.8e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—TYMS—breast cancer	2.1e-07	4.79e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ALB—breast cancer	2.1e-07	4.78e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCND1—breast cancer	2.1e-07	4.77e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NQO1—breast cancer	2.09e-07	4.77e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SLC2A1—breast cancer	2.09e-07	4.77e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—JUN—breast cancer	2.09e-07	4.76e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTM1—breast cancer	2.08e-07	4.73e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NCOR1—breast cancer	2.08e-07	4.73e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.08e-07	4.73e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.08e-07	4.73e-06	CbGpPWpGaD
Estradiol—ALB—Hemostasis—AKT1—breast cancer	2.08e-07	4.73e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CTNNB1—breast cancer	2.08e-07	4.73e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MMP9—breast cancer	2.03e-07	4.63e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN1A—breast cancer	2.03e-07	4.62e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTEN—breast cancer	2.02e-07	4.61e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—NOS3—breast cancer	2.01e-07	4.58e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP1B1—breast cancer	2.01e-07	4.57e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GPX1—breast cancer	1.99e-07	4.53e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CAV1—breast cancer	1.98e-07	4.52e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CG—breast cancer	1.98e-07	4.51e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK8—breast cancer	1.98e-07	4.51e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP1A1—breast cancer	1.97e-07	4.49e-06	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CA—breast cancer	1.97e-07	4.48e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.97e-07	4.48e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CB—breast cancer	1.96e-07	4.47e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ERCC2—breast cancer	1.95e-07	4.45e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CD—breast cancer	1.95e-07	4.44e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTGS2—breast cancer	1.95e-07	4.43e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CD—breast cancer	1.94e-07	4.42e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CG—breast cancer	1.93e-07	4.4e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ALB—breast cancer	1.93e-07	4.39e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NCOA1—breast cancer	1.91e-07	4.36e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.89e-07	4.31e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP19A1—breast cancer	1.89e-07	4.3e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—STK11—breast cancer	1.89e-07	4.3e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SRC—breast cancer	1.88e-07	4.27e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CB—breast cancer	1.85e-07	4.22e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NOS3—breast cancer	1.84e-07	4.2e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTGS2—breast cancer	1.84e-07	4.19e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—MTHFR—breast cancer	1.84e-07	4.18e-06	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CA—breast cancer	1.84e-07	4.18e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—NOS3—breast cancer	1.83e-07	4.17e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—VEGFA—breast cancer	1.83e-07	4.16e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—STAT3—breast cancer	1.81e-07	4.12e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CG—breast cancer	1.81e-07	4.11e-06	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CA—breast cancer	1.8e-07	4.11e-06	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—AKT1—breast cancer	1.79e-07	4.08e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—COMT—breast cancer	1.75e-07	3.99e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTP1—breast cancer	1.75e-07	3.98e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CD—breast cancer	1.74e-07	3.97e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK3—breast cancer	1.73e-07	3.94e-06	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—AKT1—breast cancer	1.72e-07	3.92e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—HMOX1—breast cancer	1.72e-07	3.92e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ALB—breast cancer	1.72e-07	3.92e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ITPR1—breast cancer	1.72e-07	3.91e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CB—breast cancer	1.7e-07	3.87e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CD—breast cancer	1.7e-07	3.87e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTEN—breast cancer	1.7e-07	3.86e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CAV1—breast cancer	1.69e-07	3.86e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CB—breast cancer	1.69e-07	3.85e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS2—breast cancer	1.68e-07	3.84e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MYC—breast cancer	1.68e-07	3.83e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ALB—breast cancer	1.68e-07	3.82e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TGFB1—breast cancer	1.68e-07	3.82e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS2—breast cancer	1.68e-07	3.82e-06	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CA—breast cancer	1.67e-07	3.8e-06	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CA—breast cancer	1.66e-07	3.77e-06	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CA—breast cancer	1.65e-07	3.77e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ABCB1—breast cancer	1.65e-07	3.76e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EGFR—breast cancer	1.64e-07	3.75e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NOS3—breast cancer	1.64e-07	3.75e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—TYMS—breast cancer	1.62e-07	3.7e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.62e-07	3.69e-06	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—AKT1—breast cancer	1.61e-07	3.66e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NOS3—breast cancer	1.6e-07	3.66e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.6e-07	3.65e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTM1—breast cancer	1.6e-07	3.65e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NCOR1—breast cancer	1.6e-07	3.65e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTEN—breast cancer	1.6e-07	3.65e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CD—breast cancer	1.59e-07	3.62e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ALB—breast cancer	1.57e-07	3.57e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KRAS—breast cancer	1.55e-07	3.54e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CG—breast cancer	1.54e-07	3.52e-06	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CA—breast cancer	1.54e-07	3.51e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GPX1—breast cancer	1.54e-07	3.5e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP1A1—breast cancer	1.52e-07	3.46e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CB—breast cancer	1.52e-07	3.46e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ERCC2—breast cancer	1.51e-07	3.44e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS2—breast cancer	1.5e-07	3.43e-06	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—AKT1—breast cancer	1.5e-07	3.42e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NOS3—breast cancer	1.5e-07	3.41e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CB—breast cancer	1.48e-07	3.37e-06	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—AKT1—breast cancer	1.47e-07	3.36e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTEN—breast cancer	1.47e-07	3.35e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS2—breast cancer	1.47e-07	3.34e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTEN—breast cancer	1.46e-07	3.33e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CA—breast cancer	1.43e-07	3.25e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—MTHFR—breast cancer	1.42e-07	3.23e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CB—breast cancer	1.38e-07	3.15e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—breast cancer	1.38e-07	3.14e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS2—breast cancer	1.37e-07	3.12e-06	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—AKT1—breast cancer	1.36e-07	3.11e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CD—breast cancer	1.36e-07	3.09e-06	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—AKT1—breast cancer	1.35e-07	3.08e-06	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—AKT1—breast cancer	1.35e-07	3.08e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ALB—breast cancer	1.34e-07	3.05e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HRAS—breast cancer	1.32e-07	3.01e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTEN—breast cancer	1.31e-07	2.99e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CAV1—breast cancer	1.31e-07	2.98e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NOS3—breast cancer	1.28e-07	2.92e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTEN—breast cancer	1.28e-07	2.92e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL6—breast cancer	1.26e-07	2.88e-06	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—AKT1—breast cancer	1.26e-07	2.87e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CA—breast cancer	1.2e-07	2.73e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTEN—breast cancer	1.2e-07	2.72e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CG—breast cancer	1.19e-07	2.71e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CB—breast cancer	1.18e-07	2.69e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS2—breast cancer	1.17e-07	2.67e-06	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AKT1—breast cancer	1.17e-07	2.66e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CA—breast cancer	1.13e-07	2.58e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CD—breast cancer	1.05e-07	2.38e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CA—breast cancer	1.04e-07	2.36e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALB—breast cancer	1.03e-07	2.35e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CA—breast cancer	1.03e-07	2.35e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTEN—breast cancer	1.02e-07	2.33e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NOS3—breast cancer	9.89e-08	2.25e-06	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—AKT1—breast cancer	9.78e-08	2.23e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CA—breast cancer	9.25e-08	2.11e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—AKT1—breast cancer	9.24e-08	2.1e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CB—breast cancer	9.13e-08	2.08e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS2—breast cancer	9.04e-08	2.06e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CA—breast cancer	9.03e-08	2.06e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AKT1—breast cancer	8.47e-08	1.93e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CA—breast cancer	8.44e-08	1.92e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—AKT1—breast cancer	8.42e-08	1.92e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTEN—breast cancer	7.89e-08	1.8e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AKT1—breast cancer	7.56e-08	1.72e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AKT1—breast cancer	7.38e-08	1.68e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CA—breast cancer	7.21e-08	1.64e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AKT1—breast cancer	6.89e-08	1.57e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AKT1—breast cancer	5.89e-08	1.34e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CA—breast cancer	5.56e-08	1.27e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AKT1—breast cancer	4.54e-08	1.04e-06	CbGpPWpGaD
